Murphy USA
MUSA
511.52
-1.51
-0.29%
Murphy USA
US · MUSA
#1522 by market cap
Listed 1970
511.52
-1.51
-0.29%
Live - 5344 symbols - heartbeat 560s ago
· 2026-10-08 07:29
Pre-market
523.00
+2.24%
After-hours
511.52
0.00%
- Market cap
- 9.40B
- P/E (TTM)i
- 15.65
- P/Bi
- 12.01
- EPSi
- 24.10
- Div yieldi
- 0.48%
- 52W posi
- 57%
Reader sentiment
Are you bullish or bearish on MUSA?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 7.18, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -4.25% YoY
Margins
- Gross margin
- 12.17%
- Operating margin
- 3.81%
- Net margin
- 2.43%
Key ratios & quality
- Enterprise valuei
- 11.58B
- Altman Z-Scorei
- 7.18
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 14.36B | 14.03B | 11.26B | 17.36B | 23.45B | 21.53B | 20.24B | 19.38B |
| Gross profit | 1.09B | 1.13B | 1.44B | 1.85B | 2.40B | 2.31B | 2.31B | 2.36B |
| Selling & admin expenses | 136.20M | 144.60M | 171.10M | 193.60M | 232.50M | 240.50M | 235.40M | 231.50M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 275.80M | 268.30M | 559.40M | 612.90M | 967.80M | 826.80M | 755.60M | 739.20M |
| Pretax profit | 273.90M | 202.40M | 509.10M | 521.90M | 883.80M | 734.40M | 651.60M | 609.20M |
| Tax | 60.30M | 47.60M | 123.00M | 125.00M | 210.90M | 177.60M | 149.10M | 138.60M |
| Net profit | 213.60M | 154.80M | 386.10M | 396.90M | 672.90M | 556.80M | 502.50M | 470.60M |
| Basic EPS | 7 | 5 | 13 | 15 | 29 | 26 | 24 | 24 |
| Diluted EPS | 6.48 | 4.86 | 13.08 | 14.92 | 28.10 | 25.49 | 24.11 | 24.10 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 4.53B | 5.01B | 5.11B | 4.74B | 4.82B | 6.81B |
| Gross profit | 483.60M | 612.10M | 626.30M | 637.40M | 614.30M | 746.50M |
| Selling & admin expenses | 60.10M | 50.90M | 55.30M | 65.20M | 56.60M | 60.50M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 88.30M | 219.20M | 214.30M | 217.40M | 204.90M | 304.20M |
| Pretax profit | 61.90M | 192.50M | 173.40M | 181.40M | 176.20M | 277.60M |
| Tax | 8.70M | 46.90M | 43.50M | 39.50M | 39.90M | 68.50M |
| Net profit | 53.20M | 145.60M | 129.90M | 141.90M | 136.30M | 209.10M |
| Basic EPS | 3 | 7 | 7 | 8 | 7 | 11 |
| Diluted EPS | 2.63 | 7.36 | 6.76 | 7.53 | 7.28 | 11.27 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 570.10M | 710.80M | 625.20M | 767.80M | 726.80M | 826.50M | 748.10M | 747.80M |
| Cash & ST investments | 184.50M | 280.30M | 163.60M | 256.40M | 78.40M | 124.90M | 47.00M | 28.90M |
| Inventory | 221.50M | 227.60M | 279.10M | 292.30M | 319.10M | 341.20M | 401.60M | 413.00M |
| Total assets | 2.36B | 2.69B | 2.69B | 4.05B | 4.12B | 4.34B | 4.54B | 4.73B |
| Total current liabilities | 478.10M | 505.00M | 531.10M | 675.30M | 854.20M | 872.80M | 947.90M | 929.10M |
| Short-term debt | 21.20M | 38.80M | 51.20M | 33.10M | 35.50M | 37.10M | 39.40M | 44.80M |
| Long-term debt | 842.10M | 999.30M | 951.20M | 1.80B | 1.79B | 1.78B | 1.83B | 2.16B |
| Total liabilities | 1,553,500,000.00 | 1,884,200,000.00 | 1,901,600,000.00 | 3,241,000,000.00 | 3,482,500,000.00 | 3,511,200,000.00 | 3,701,500,000.00 | 4,102,300,000.00 |
| Total equity | 807.30M | 803.00M | 784.10M | 807.20M | 640.70M | 828.90M | 840.10M | 623.50M |
| Retained earnings | 1.21B | 1.36B | 1.74B | 2.11B | 2.76B | 3.28B | 3.74B | 4.17B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 716.40M | 776.40M | 763.30M | 747.80M | 871.10M | 1.01B |
| Cash & ST investments | 49.40M | 54.10M | 42.80M | 28.90M | 118.60M | 175.40M |
| Inventory | 364.40M | 397.50M | 387.20M | 413.00M | 363.30M | 417.40M |
| Total assets | 4.50B | 4.62B | 4.68B | 4.73B | 4.87B | 5.09B |
| Total current liabilities | 891.80M | 976.10M | 940.20M | 929.10M | 1.05B | 1.09B |
| Short-term debt | 15.60M | 14.50M | 16.60M | 44.80M | 19.20M | 19.10M |
| Long-term debt | 1.97B | 2.07B | 2.22B | 2.16B | 2.14B | 2.17B |
| Total liabilities | 3,782,900,000.00 | 3,976,100,000.00 | 4,130,600,000.00 | 4,102,300,000.00 | 4,207,700,000.00 | 4,302,300,000.00 |
| Total equity | 719.60M | 646.10M | 546.00M | 623.50M | 658.70M | 782.70M |
| Retained earnings | 3.79B | 3.92B | 4.04B | 4.17B | 4.30B | 4.49B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 398.70M | 313.30M | 563.70M | 737.40M | 994.70M | 784.00M | 847.60M | 813.90M |
| Depreciation & amortization | 134.00M | 152.20M | 161.00M | 212.60M | 220.40M | 228.70M | 248.00M | 276.80M |
| Free cash flow | 194.40M | 108.50M | 333.00M | 462.70M | 689.40M | 448.40M | 389.50M | 374.30M |
| Dividends paid | 0 | 0 | -6.90M | -27.30M | -29.90M | -33.40M | -36.80M | -41.50M |
| Stock buybacks / issuance | -144.40M | -165.80M | -399.60M | -355.00M | -806.40M | -333.20M | -445.70M | -649.90M |
| Ending cash balance | 184.50M | 280.30M | 163.60M | 256.40M | 60.50M | 117.80M | 47.00M | 28.90M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 128.50M | 255.10M | 184.80M | 245.50M | 320.00M | 235.00M |
| Depreciation & amortization | 68.20M | 66.00M | 69.90M | 72.70M | 72.10M | 72.20M |
| Free cash flow | 40.70M | 137.10M | 67.70M | 128.80M | 221.70M | 123.30M |
| Dividends paid | -9.80M | -9.80M | -10.10M | -11.80M | -11.70M | -11.80M |
| Stock buybacks / issuance | -150.00M | -213.80M | -219.20M | -66.90M | -70.50M | -82.30M |
| Ending cash balance | 49.40M | 54.10M | 42.80M | 28.90M | 118.60M | 175.40M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 27.64 | 19.23 | 48.65 | 49.88 | 92.95 | 75.78 | 60.22 | 64.31 |
| ROA %i | 9.11 | 6.13 | 14.37 | 11.79 | 16.47 | 13.16 | 11.32 | 10.16 |
| ROIC %i | 15.42 | 11.07 | 23.38 | 19.07 | 24.75 | 21.00 | 18.30 | 16.92 |
| 5-year avg ROE %i | 29.02 | 26.43 | 31.89 | 35.92 | 47.67 | 57.30 | 65.50 | 68.63 |
| EBIT margin %i | 2.28 | 1.83 | 4.97 | 3.48 | 4.13 | 3.87 | 3.70 | 3.71 |
| FCF / sales %i | 1.35 | 0.77 | 2.96 | 2.67 | 2.94 | 2.08 | 1.92 | 1.93 |
| Current ratioi | 1.19 | 1.41 | 1.18 | 1.14 | 0.85 | 0.95 | 0.79 | 0.80 |
| Quick ratioi | 0.68 | 0.90 | 0.63 | 0.67 | 0.42 | 0.53 | 0.33 | 0.33 |
| Debt / assetsi | 36.57 | 38.63 | 42.63 | 55.39 | 55.09 | 52.35 | 52.15 | 58.04 |
| LT debt / equityi | 104.31 | 124.45 | 139.48 | 273.66 | 349.01 | 269.63 | 277.23 | 432.75 |
| Interest coveragei | 6.18 | 4.69 | 10.94 | 7.33 | 11.36 | 8.46 | 7.71 | 6.49 |
| Revenue CAGR (3Y) %i | 4.19 | 6.57 | -4.24 | 6.52 | 18.66 | 24.10 | 5.26 | -6.15 |
| Net income CAGR (3Y) %i | 6.60 | -11.26 | 16.32 | 22.94 | 63.20 | 12.98 | 8.18 | -11.24 |
| FCF CAGR (3Y) %i | 163.60 | 12.95 | 136.11 | 33.52 | 85.22 | 10.43 | -5.58 | -18.42 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 65.24 | 67.31 | 68.48 | 64.31 | 80.35 | 86.39 |
| ROA %i | 11.12 | 10.84 | 10.38 | 10.16 | 11.82 | 12.72 |
| ROIC %i | 18.13 | 18.03 | 17.14 | 16.92 | 19.58 | 20.90 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 3.66 | 3.75 | 3.67 | 3.71 | 4.26 | 4.30 |
| FCF / sales %i | 1.86 | 1.87 | 1.90 | 1.93 | 2.82 | 2.52 |
| Current ratioi | 0.80 | 0.80 | 0.81 | 0.80 | 0.83 | 0.92 |
| Quick ratioi | 0.36 | 0.36 | 0.37 | 0.33 | 0.45 | 0.51 |
| Debt / assetsi | 55.17 | 56.03 | 58.88 | 58.04 | 55.26 | 53.80 |
| LT debt / equityi | 343.05 | 398.56 | 501.26 | 432.75 | 405.33 | 347.06 |
| Interest coveragei | 7.47 | 7.28 | 6.76 | 6.49 | 7.32 | 7.97 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Marketing is the largest reported line at 100.00% of revenue, across 2 reported segments.
- The next-largest line, Other revenues, is a distant second at 0.00% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Marketing100.00%
Quote time 2026-10-08 07:29:51 · For reference only, not investment advice and not tailored to your situation.